Li, Chengtai. 2026. “Should CRISPR-Cas9 Be Used in Human Embryos to Eliminate Genetic Diseases? Public Attitudes and Benefit–Risk Analysis”. MedScien 4 (1):6812. https://doi.org/10.61173/as39n470.